Giampiero De Luca
Senior Vice President,
Licensing & Intellectual Property, Merck Serono SA
(Switzerland)
Allen Norris
Vice President, Head Group IP,
UCB Pharma SA (Belgium)
Panel Moderator:
Kristina Cornish, Partner, Kilburn & Strode (UK)
John Beatty
Patent Procedures Management,
European Patent Office (Germany)
Dr. Sjoerd Hoekstra, Director Biotechnology
Department, European Patent Office
(The Netherlands)
Tony Rollins, Managing Counsel European Patents,
Merck & Co. (UK)
Tobias Roeser, German and European Patent
Attorney, Sandoz AG (Germany)
Marion Rees, IP Manager
Oxford Nanopore Technologies (UK)
Dr. Aliki Nichogiannopoulou, Director
Biotechnology, European Patent Office (Germany)
Leo Polz, German and European Patent Attorney,
Hoffmann Eitle (Germany)
Martin Chakraborty, Partner, Hogan Lovells (Germany)
Adam Cooke, Partner, Hogan Lovells (UK)
Tim Powell, Partner, Powell Gilbert (UK)
Paul Commander, European Patent Attorney,
Eli Lilly and Company Limited (UK)
Dr. Luke Kempton, Partner, Wragge & Co
Lawrence Cullen, Deputy Director
(Biotechnology & Pharmaceuticals), UKIPO (UK)
John Carlin, Partner, Fitzpatrick Cella (US)
Fiona Bor, Senior Patent Counsel Patent Department,
Teva Europe (UK)
Mark Einerhand, Partner, Vereenigde (Netherlands)
Joachim Wachenfeld, Partner, Vossius & Partner
(Germany)
Rob J. Aerts, Principal Patent Attorney, Abbott
Healthcare Products B.V. (The Netherlands)
Nina White, Partner, Boult Wade Tennant (UK)
Jürgen Meier, Partner, Vossius & Partner (Germany)
Dr. Philip Weber, Partner, Frank B. Dehn & Co. (UK)
Anthony Tridico, Partner, Finnegan (US/Belgium)
Dr. Rouget Henschel, Partner, Foley & Lardner (US)
Ian Hiscock, Head, CIP Litigation EU & OUS,
Novartis International AG (Switzerland)
Duncan Curley, Head of Patents, Innovate Legal (UK)